Chugai Pharmaceutical Co., Ltd.August 30, 2019

FDA 483 - Chugai Pharmaceutical Co., Ltd. - August 30, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chugai Pharmaceutical Co., Ltd.

Record Details

Chugai Pharmaceutical Co., Ltd. in Fujieda, Japan was inspected from August 26-30, 2019, revealing significant deficiencies. The firm failed to thoroughly review unexplained discrepancies, leading to the release of drug batches with foreign matter and inadequate investigation into contamination sources. Additionally, the quality control unit did not ensure proper humidity storage conditions for empty capsules, potentially affecting their quality and purity.

Company: Chugai Pharmaceutical Co., Ltd.
Inspection Date: August 30, 2019
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Jose M. Cayuela

Open in Dashboard

ID · e187fb7d-6a0a-451b-b1a8-e8f2159cfd4a